OPKO Health/OPK

$1.05

2.35%
-
1D1W1MYTD1YMAX

About OPKO Health

OPKO Health, Inc. is a healthcare company. The Company's segments include diagnostics and pharmaceuticals. The diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. The pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates laboratory divisions, such as BioReference Health, GenPath and GenPath. Its Pharmaceutical Business has one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including pharmaceutical compounds, Oxyntomodulin, Biologics, Factor VIIa-CTP and others. It also owns an active pharmaceutical ingredients manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Ticker

OPK

Sector

Tervishoid

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Phillip Frost

Employees

4,196

Headquarters

Miami, United States

OPKO Health Metrics

BasicAdvanced
$731.31M
Market cap
-
P/E ratio
-$0.28
EPS
1.79
Beta
-
Dividend rate

What the Analysts think about OPKO Health

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 6 analysts.
312.38% upside
High $8.50
Low $2.00
$1.05
Current price
$4.33
Average price target

OPKO Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-47.28% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$178.5M
-32.74%
Net income
$-84.4M
330.61%
Profit margin
-47.28%
540.65%

OPKO Health Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 10%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.11
-$0.02
-$0.03
-$0.11
-
Expected
-$0.11
-$0.08
-$0.07
-$0.10
-$0.09
Surprise
-2.94%
-73.91%
-63.62%
10%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell OPKO Health stock

Buy or sell OPKO Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing